NCT01256372View on ClinicalTrials.gov

An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

77

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

August 31, 2011

Conditions

Cardiac SurgeryCoronary Artery BypassAortic AneurysmValve SurgeryKidney Diseases

Interventions

DRUG

AP214

AP214

DRUG

Placebo

Placebo; intravenous infusion

Trial Locations (1)

2100

University Hospital Copenhagen, Rigshospitalet, Copenhagen

Sponsors

Lead Sponsor

Action Pharma A/S

All Listed Sponsors

lead

Action Pharma A/S

INDUSTRY

NCT01256372 - An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter